Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 165637, 10 pages
http://dx.doi.org/10.1155/2009/165637
Research Article

Characterization of Multidrug Resistant ESBL-Producing Escherichia coli Isolates from Hospitals in Malaysia

1Microbiology Division, Institute of Biological Science, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
2Specialized Diagnostic Centre, Institute of Medical Research, Jalan Pahang, 50588 Kuala Lumpur, Malaysia
3Faculty of Agriculture and Biotechnology, Darul Iman University, Malaysia, 20400 Kuala Terengganu, Malaysia
4Department of Medical Microbiology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia

Received 11 February 2009; Accepted 11 June 2009

Academic Editor: Vanessa Sperandio

Copyright © 2009 King-Ting Lim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Y. Kang, Y. S. Jeong, J. Y. Oh et al., “Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea,” Journal of Antimicrobial Chemotherapy, vol. 55, no. 5, pp. 639–644, 2005. View at Publisher · View at Google Scholar
  2. F. C. Tenover, P. M. Raney, P. P. Williams et al., “Evaluation of the NCCLS extended-spectrum ß-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE,” Journal of Clinical Microbiology, vol. 41, no. 7, pp. 3142–3146, 2003. View at Publisher · View at Google Scholar
  3. R. Bonnet, “Growing group of extended-spectrum β-lactamases: the CTX-M enzymes,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 1, pp. 1–14, 2004. View at Publisher · View at Google Scholar
  4. F. Perez, A. Endimiani, K. M. Hujer, and R. A. Bonomo, “The continuing challenge of ESBLs,” Current Opinion in Pharmacology, vol. 7, no. 5, pp. 459–469, 2007. View at Publisher · View at Google Scholar
  5. L. G. Dos Anjos Borges, V. D. Vechia, and G. Corcao, “Characterisation and genetic diversity via REP-PCR of Escherichia coli isolates from polluted waters in southern Brazil,” FEMS Microbiology Ecology, vol. 45, no. 2, pp. 173–180, 2003. View at Publisher · View at Google Scholar
  6. G. Subramaniam, S. Palasubramaniam, and P. Navaratnam, “SHV-5 extended-spectrum β-lactamases in clinical isolates of Escherichia coli in Malaysia,” Indian Journal of Medical Microbiology, vol. 24, no. 3, pp. 205–207, 2006. View at Google Scholar
  7. R. Latha, T. S. Suryanarayanan, and M. S. Swaminathan, “Genetic diversity in Acremonium endophytes isolated from warm-season grasses as revealed by RAPD markers,” Journal of Plant Biochemistry and Biotechnology, vol. 13, no. 1, pp. 39–42, 2004. View at Google Scholar
  8. S. Chatellier, M. Gottschalk, R. Higgins, R. Brousseau, and J. Harel, “Relatedness of Streptococcus suis serotype 2 isolates from different geographic origins as evaluated by molecular fingerprinting and phenotyping,” Journal of Clinical Microbiology, vol. 37, no. 2, pp. 362–366, 1999. View at Google Scholar
  9. M. M. Navia, L. Capitano, J. Ruiz et al., “Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania,” Journal of Clinical Microbiology, vol. 37, no. 10, pp. 3113–3117, 1999. View at Google Scholar
  10. A. Oliver, L. M. Weigel, J. K. Rasheed, J. E. McGowan Jr., P. Raney, and F. C. Tenover, “Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 12, pp. 3829–3836, 2002. View at Publisher · View at Google Scholar
  11. L. Pagani, E. Dell'Amico, R. Migliavacca et al., “Multiple CTX-M-type extended-spectrum ß-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in Northern Italy,” Journal of Clinical Microbiology, vol. 41, no. 9, pp. 4264–4269, 2003. View at Publisher · View at Google Scholar
  12. H. Pai, C.-I. Kang, J.-H. Byeon et al., “Epidemiology and clinical features of bloodstream infections caused by AmpC-type-ß-lactamase-producing Klebsiella pneumoniae,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 10, pp. 3720–3728, 2004. View at Publisher · View at Google Scholar
  13. X. Jiang, Z. Zhang, M. Li, D. Zhou, F. Ruan, and Y. Lu, “Detection of extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 9, pp. 2990–2995, 2006. View at Publisher · View at Google Scholar
  14. E. Machado, R. Cantón, F. Baquero et al., “Integron content of extended-spectrum-ß-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 5, pp. 1823–1829, 2005. View at Publisher · View at Google Scholar
  15. V. M. Ensor, D. M. Livermore, and P. M. Hawkey, “A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum β-lactamases,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 3, pp. 387–395, 2007. View at Publisher · View at Google Scholar
  16. N. Woodford, M. E. Ward, M. E. Kaufmann et al., “Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum ß-lactamases in the UK,” Journal of Antimicrobial Chemotherapy, vol. 54, no. 4, pp. 735–743, 2004. View at Publisher · View at Google Scholar
  17. P. Giakkoupi, A. Xanthaki, M. Kanelopoulo et al., “VIM-1 metallo-ß-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals,” Journal of Clinical Microbiology, vol. 41, no. 8, pp. 3893–3896, 2003. View at Publisher · View at Google Scholar
  18. P. E. Coudron, N. D. Hanson, and M. W. Climo, “Occurrence of extended-spectrum and ampC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases,” Journal of Clinical Microbiology, vol. 41, no. 2, pp. 772–777, 2003. View at Publisher · View at Google Scholar
  19. F. J. De Bruijn, “Use of repetitive (repetitive extragenic palindromic and enterobacterial repetitive intergeneric consensus) sequences and the polymerase chain reaction to fingerprint the genomes of Rhizobium meliloti isolates and other soil bacteria,” Applied and Environmental Microbiology, vol. 58, no. 7, pp. 2180–2187, 1992. View at Google Scholar
  20. S. Tofteland, B. Haldorsen, K. H. Dahl et al., “Effects of phenotype and genotype on methods for detection of extended-spectrum-ß-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway,” Journal of Clinical Microbiology, vol. 45, no. 1, pp. 199–205, 2007. View at Publisher · View at Google Scholar
  21. K. L. Thong, K. S. Lai, S. D. Puthucheary, Y. T. Koh, N. Ahmad, and R. M. Yassin, “Subtyping of Salmonella enterica serovar Muenchen by pulsed-field gel electrophoresis, plasmid profiling and antimicrobial susceptibility testing,” Malaysian Journal of Science, vol. 26, no. 2, pp. 1–13, 2007. View at Google Scholar
  22. Clinical and Laboratory Standards Institute, “Performance standards for antimicrobial susceptibility testing,” Fifteenth informational supplement. Approved standard MS100-S16. Wayne, PA: CLSI; 2006.
  23. V. Jarlier, M. H. Nicolas, G. Fournier, and A. Philippon, “Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns,” Reviews of Infectious Diseases, vol. 10, no. 4, pp. 867–878, 1988. View at Google Scholar
  24. C. Mugnaioli, F. Luzzaro, F. De Luca et al., “CTX-M-type extended-spectrum ß-lactamases in Italy: molecular epidemiology of an emerging countrywide problem,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 8, pp. 2700–2706, 2006. View at Publisher · View at Google Scholar
  25. M. V. Villegas, A. Correa, F. Perez, M. C. Miranda, T. Zuluaga, and J. P. Quinn, “Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals,” Diagnostic Microbiology and Infectious Disease, vol. 49, no. 3, pp. 217–222, 2004. View at Publisher · View at Google Scholar
  26. Y. Yu, S. Ji, Y. Chen et al., “Resistance of strains producing extended-spectrum ß-lactamases and genotype distribution in China,” Journal of Infection, vol. 54, no. 1, pp. 53–57, 2007. View at Publisher · View at Google Scholar
  27. N. Alhaj, N. S. Mariana, A. R. Raha, and Z. Ishak, “Prevalence of antibiotic resistance among Escherichia coli from different sources in Malaysia,” Research Journal of Pharmacology, vol. 1, pp. 44–49, 2007. View at Google Scholar
  28. R. Colodner, Z. Samra, N. Keller et al., “First national surveillance of susceptibility of extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel,” Diagnostic Microbiology and Infectious Disease, vol. 57, no. 2, pp. 201–205, 2007. View at Publisher · View at Google Scholar
  29. P. A. Bradford, “Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat,” Clinical Microbiology Reviews, vol. 14, no. 4, pp. 933–951, 2001. View at Publisher · View at Google Scholar
  30. D. M. Livermore, “β-lactamases in laboratory and clinical resistance,” Clinical Microbiology Reviews, vol. 8, no. 4, pp. 557–584, 1995. View at Google Scholar
  31. D. M. Livermore, R. Canton, M. Gniadkowski et al., “CTX-M: changing the face of ESBLs in Europe,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 2, pp. 165–174, 2007. View at Publisher · View at Google Scholar
  32. A. van Essen-Zandbergen, H. Smith, K. Veldman, and D. Mevius, “Occurrence and characteristics of class 1, 2 and 3 integrons in Escherichia coli, Salmonella and Campylobacter spp. in the Netherlands,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 4, pp. 746–750, 2007. View at Publisher · View at Google Scholar
  33. I. S. Henriques, F. Fonseca, A. Alves, M. J. Saavedra, and A. Correia, “Occurrence and diversity of integrons and β-lactamase genes among ampicillin-resistant isolates from estuarine waters,” Research in Microbiology, vol. 157, no. 10, pp. 938–947, 2006. View at Publisher · View at Google Scholar
  34. C. Eckert, V. Gautier, M. Saladin-Allard et al., “Dissemination of CTX-M-type ß-lactamases among clinical isolates of Enterobacteriaceae in Paris, France,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 4, pp. 1249–1255, 2004. View at Publisher · View at Google Scholar
  35. S. Lavilla, J. J. González-López, M. Sabaté et al., “Prevalence of qnr genes among extended-spectrum ß-lactamase-producing enterobacterial isolates in Barcelona, Spain,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 2, pp. 291–295, 2008. View at Publisher · View at Google Scholar
  36. C.-R. Li, Y. Li, and P.-A. Zhang, “Dissemination and spread of CTX-M extended-spectrum β-lactamases among clinical isolates of Klebsiella pneumoniae in central China,” International Journal of Antimicrobial Agents, vol. 22, no. 5, pp. 521–525, 2003. View at Publisher · View at Google Scholar
  37. D. Sompolinsky, Y. Nitzan, S. Tetry et al., “Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel,” Journal of Antimicrobial Chemotherapy, vol. 55, no. 1, pp. 119–122, 2005. View at Publisher · View at Google Scholar